Personalized Breast Cancer Screening

NAActive, not recruitingINTERVENTIONAL
Enrollment

2,200

Participants

Timeline

Start Date

February 2, 2024

Primary Completion Date

January 1, 2027

Study Completion Date

December 31, 2034

Conditions
Breast Cancer
Interventions
OTHER

Risk stratified arm

"* Complete a questionnaire about family history of breast cancer, lifestyle, reproductive history (baseline)~* Measurement of height and weight (baseline)~* Complete a mammography (baseline and every 1-4 years according to the risk-group)~* Complete questionnaires about quality of life, breast cancer worry and anxiety (safety measures) (baseline, day 180, 365, and 800)~* Provide a blood sample for analysis of 313 common genetic variants associated with risk of breast cancer (baseline)~* Receive a screening schedule recommendation."

OTHER

Control arm

"* Complete a questionnaire about family history of breast cancer, lifestyle, reproductive history (baseline)~* Measurement of height and weight (baseline)~* Complete a mammography (baseline and every second year)~* Complete questionnaires about quality of life, breast cancer worry and anxiety (safety measures) (baseline, day 180, 365, and 800)"

Trial Locations (1)

2900

Dept. of Breast Examinations, Herlev Gentofte Hospital, Copenhagen University Hospital, Gentofte Municipality

All Listed Sponsors
collaborator

Danish Cancer Society

OTHER

collaborator

University of Cambridge

OTHER

collaborator

University of Aarhus

OTHER

collaborator

The Novo Nordic Foundation

OTHER

lead

Herlev and Gentofte Hospital

OTHER

NCT06060938 - Personalized Breast Cancer Screening | Biotech Hunter | Biotech Hunter